In a shocking development for the Atlanta Braves, outfielder Jurickson Profar has been handed a 162-game suspension after testing positive for a performance-enhancing substance. The ban, which takes effect Friday, would effectively sideline Profar for the entirety of the 2026 season, including any postseason appearances, and would result in a significant loss of salary if upheld. According to Ken Rosenthal of The Athletic, the Players Association is gearing up to contest the suspension, planning to file a grievance that could delay the enforcement of the ban as it navigates through MLB’s Joint Drug Prevention and Treatment Program.
This unexpected turn of events raises immediate questions about the Braves’ outfield depth as they prepare for the upcoming season. Profar was expected to play a pivotal role in the lineup, and his absence forces the team to reassess their roster strategy, prompting them to explore both internal solutions and potential external acquisitions to fill the void left by the suspended player.
In other MLB news, Milwaukee Brewers starter Quinn Priester is currently lagging behind in his preparation for the season due to wrist soreness, raising concerns about his availability for Opening Day. Additionally, the league has seen another outfielder, Johan Rojas of the Philadelphia Phillies, receive an 80-game suspension following a failed performance-enhancing drug test. These developments illustrate the ongoing challenges teams face as they manage player health and compliance with league policies.
Note: This recap is an independently written summary based on publicly available reporting.
TB
BOS
LAD
NYY
CHW
TOR
TEX
ATL
MIA
MIL
MIN
CHC
SD
KC
BAL
HOU
CIN
COL
DET
LAA
STL
ARI
WSH
OAK
SF
SEA
PIT
CLE
NYM
PHI